Syneron Medical Ltd

Type: Company
Name: Syneron Medical Ltd
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Italy General Surgery Market, 2020

FOR IMMEDIATE RELEASE, Illinois – United States – September 19,2014 (PR Buzz): The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, ... [Published Pettinga Financial Advisors - Sep 19 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Global Body Contouring Devices Market - Industry Analysis and Forecast till 2019

Body contouring is a surgical procedure that involves alteration of the body parts such as torso, upper arms, thighs, buttocks, and chest with an intention to improve the overall appearance of the body. This is more effective for those who already have ... [Published MyNewsDesk - Sep 17 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 4 reports

Syneron Announces Details for Upcoming Investor Meeting

YOKNEAM, Israel, Sept. 15, 2014 /PRNewswire/ -- Syneron Medical LtdThe meeting will be hosted by Syneron's management team, including:The meeting will include presentations from three physician guest speakers with direct experience with the UltraShape ... [Published BusinessWeek - Sep 15 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 3 reports

Syneron's elure™ Wins Allure Magazine's BEST OF BEAUTY Award For The Fourth Consecutive Year

Allure Magazine selects winners based on real, noticeable results. Among the thousands of beauty products launched every year, these are the products that stand out as tried and tested editor favorites for their incredible efficacy."We are proud to earn ... [Published Industrial Info Financials - Sep 15 2014]
First reported Sep 11 2014 - Updated Sep 11 2014 - 1 reports

Patent Application Titled "Hair Removal Apparatus for Personal Use and the Method of Using Same" Published Online

By a News Reporter-Staff News Editor at Politics & Government Week -- According to news reporting originating from Washington, D.C. , by VerticalNews journalists, a patent application by the inventors Eckhouse, Shimon ( Haifa , IL); Kutscher, Tuvia Dror ... [Published 4 Traders - Sep 11 2014]
Entities: Illustrator, Radiation, RF
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

Syneron Medical (ELOS) Shows Strength: Stock Rises 5.2% - Tale of the Tape

Syneron Medical Ltd. ( ELOS ) was a big mover last session, as its shares rose over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock ... [Published Zacks.com - Sep 03 2014]
First reported Sep 02 2014 - Updated Sep 03 2014 - 2 reports

Syneron Medical (ELOS) Shows Strength: Stock Rises 5.2%

Syneron Medical Ltd. ( ELOS ) was a big mover last session, as its shares rose over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock ... [Published Yahoo! Finance - Sep 03 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Syneron Medical Introduces New FDA-Cleared 5mm Spot Size for Treatment of Onychomycosis

By a News Reporter-Staff News Editor at Pharma Business Week -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced the market launch of its proprietary handpiece featuring a new 5-millimeter spot size for the Gentle ... [Published 4 Traders - Aug 21 2014]
First reported Aug 14 2014 - Updated Aug 15 2014 - 4 reports

Syneron Medical launches 5mm spot size handpiece to treat nail fungus

Aesthetic device company Syneron Medical has introduced new FDA-cleared handpiece to treat onychomycosis (nail fungus).Featuring a new 5mm spot size for the Gentle Pro Nd:YAG Laser Series, the device expands the functionality of the GentleYAG Pro and ... [Published Medical Devices Business Review - Aug 15 2014]
First reported Aug 14 2014 - Updated Aug 15 2014 - 2 reports

Tracking Seth Klarman's Baupost Group Holdings - Q2 2014 Update

Summary Seth Klarman’s US long portfolio increased a whopping ~48% from $4.14B to $6.14B this quarter as Idenix Pharmaceuticals and Micron Technology posted outsized returns. Baupost Group added eBay Inc. this quarter while dropping BP plc. The US ... [Published Seeking Alpha - Aug 15 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 2 reports

Update: Syneron Medical Earnings

By Andy Batts :Syneron Medical (NASDAQ: ELOS ) reported net income of $2.5 million and EPS of $0.07 in the second quarter of 2014, compared to net income of $3 million, or $0.08 per share in the second quarter of 2013. Revenue in the quarter came in at ... [Published BioPortfolio - Aug 14 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

Syneron Medical to Report Second Quarter 2014 Financial Results on August 6, 2014

YOKNEAM, Israel, July 18, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release second quarter 2014 financial results before the market opens on Wednesday, August 6, 2014. ... [Published PR Newswire: Consumer Products & Retail - Jul 18 2014]

Quotes

...for our industry-leading brightening from Allure, a publication we hold in high regard," said Amit Meridor, Chief Executive Officer of Syneron. "elure represents the next generation in skin brightening products with proven clinical results and a superior safety profile, which underscores our"
"The term 'illumination sources' and 'light sources' as used in the present disclosure has the same meaning and includes sources of visible and invisible infrared radiation."

More Content

All (65) | News (32) | Reports (0) | Blogs (26) | Audio/Video (0) | Fact Sheets (1) | Press Releases (6)
sort by: Date | Relevance
Italy General Surgery Market, 2020 [Published Pettinga Financial Advisors - Sep 19 2014]
Global Body Contouring Devices Market - Industr... [Published MyNewsDesk - Sep 17 2014]
Syneron Announces Details for Upcoming Investor... [Published BusinessWeek - Sep 15 2014]
Syneron Announces Details for Upcoming Investor... [Published Nasdaq - Sep 15 2014]
Syneron Announces Details for Upcoming Investor... [Published Ask.com - Sep 15 2014]
Syneron Announces Details for Upcoming Investor... [Published PR Newswire: Consumer Products & Retail - Sep 15 2014]
Syneron's elure™ Wins Allure Magazine's BEST OF... [Published Industrial Info Financials - Sep 15 2014]
Syneron's elure™ Wins Allure Magazine's BEST OF... [Published Myrtle Beach Sun News - Sep 15 2014]
Syneron's elure™ Wins Allure Magazine's BEST OF... [Published PR Newswire: Consumer Products & Retail - Sep 15 2014]
Patent Application Titled "Hair Removal Apparat... [Published 4 Traders - Sep 11 2014]
Global Skincare Devices Market Is Expected To B... [Published Virtual Strategy Magazine - Sep 11 2014]
Research Analysts’ Downgrades for September, 3r... [Published Mideast Time - Sep 04 2014]
Syneron Medical (ELOS) Shows Strength: Stock Ri... [Published Zacks.com - Sep 03 2014]
Syneron Medical (ELOS) Shows Strength: Stock Ri... [Published Yahoo! Finance - Sep 03 2014]
Aesthetic Equipment Market Segment Forecasts up... [Published MyNewsDesk - Sep 03 2014]
Syneron Medical (ELOS) Showing Bearish Technica... [Published Individual.com - Sep 02 2014]
Syneron Medical (ELOS) Showing Bearish Technica... [Published MarketIntelligenceCenter.com - Sep 02 2014]
Syneron Medical Has Returned 9.6% Since SmarTre... [Published Comtex SmarTrend - Aug 28 2014]
Syneron Medical Has Returned 9.6% Since SmarTre... [Published Individual.com - Aug 27 2014]
A High Growth Area for Health Care Investors Th... [Published Equities.com - Aug 26 2014]
Syneron Medical Introduces New FDA-Cleared 5mm ... [Published 4 Traders - Aug 21 2014]
World Skincare Devices Market Is Expected To Re... [Published BioSpace - Aug 20 2014]
Dallas Plastic Surgeon Dr. Benjamin Bassichis i... [Published PRWeb - Aug 19 2014]
Syneron Medical (ELOS) Showing Bearish Technica... [Published MarketIntelligenceCenter.com - Aug 19 2014]
Syneron Medical (ELOS) Trading Near $10.25 Resi... [Published MarketIntelligenceCenter.com - Aug 18 2014]
Syneron launches new 5-mm spot size onychomycos... [Published Orthopedics Today - Aug 15 2014]
Syneron Medical launches 5mm spot size handpiec... [Published Medical Devices Business Review - Aug 15 2014]
Tracking Seth Klarman's Baupost Group Holdings ... [Published Seeking Alpha - Aug 15 2014]
Syneron Medical (ELOS) Trading Near $10.60 Resi... [Published MarketIntelligenceCenter.com - Aug 15 2014]
LGND Does A Deal, Q2 Revenue A Bitter Pill For ... [Published RTTNews.com - Aug 15 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Syneron Announces Details for Upcoming Investor... [Published PR Newswire: Consumer Products & Retail - Sep 15 2014]
YOKNEAM, Israel, Sept. 15, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that it will host an investor meeting on Wednesday, September 17, 2014, from 10:00 am to 1:00 pm ET in ...
Syneron's elure™ Wins Allure Magazine's BEST OF... [Published PR Newswire: Consumer Products & Retail - Sep 15 2014]
YOKNEAM, Israel, Sept. 15, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), the global leader in medical aesthetic products and technology, announced today that Allure Magazine has named elure™ Advanced Brightening Lotion its "Best Anti-Ager ...
Syneron Medical (ELOS) Showing Bearish Technica... [Published MarketIntelligenceCenter.com - Sep 02 2014]
After closing Friday at $10.04, Syneron Medical (ELOS) presents an attractive opportunity to get a 10.01% return in just 199 days, which is an annualized return of 18.36% (for comparison purposes only). To enter this trade, sell one Mar. '15 $10.00 call ...
Syneron Medical (ELOS) Showing Bearish Technica... [Published MarketIntelligenceCenter.com - Aug 19 2014]
Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with Syneron Medical (ELOS) that should provide a 10.50% return in just 213 days. Sell one Mar. '15 call at the $10.00 level for each 100 shares of Syneron ...
Syneron Medical (ELOS) Trading Near $10.25 Resi... [Published MarketIntelligenceCenter.com - Aug 18 2014]
The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on Syneron Medical (ELOS) that includes 9.86% downside protection. Sell one contract of the Mar. '15 $10.00 ...
1 2 3 4 5 6

Press Releases

sort by: Date | Relevance
Syneron Reports Second Quarter 2014 Results [Published Financial Services - Aug 06 2014]
Syneron Reports First Quarter 2014 Results [Published Financial Services - May 14 2014]
Syneron Receives US FDA Clearance to Market the... [Published Financial Services - Apr 14 2014]
Syneron's Innovative Products Featured at 34th ... [Published Financial Services - Apr 04 2014]
Syneron Sublative Technology Earns CE Mark for ... [Published Financial Services - Apr 03 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.